Free Trial
NASDAQ:TELO

Telomir Pharmaceuticals (TELO) Stock Price, News & Analysis

$5.60
-0.10 (-1.75%)
(As of 05/22/2024 ET)
Today's Range
$5.56
$6.05
50-Day Range
$4.83
$9.00
52-Week Range
$4.76
$20.72
Volume
10,501 shs
Average Volume
55,439 shs
Market Capitalization
$165.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
TELO stock logo

About Telomir Pharmaceuticals Stock (NASDAQ:TELO)

Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human stem cells. The company develops TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic intervention against age-related inflammatory conditions, such as hemochromatosis and osteoarthritis, as well as for post-chemotherapy health problems. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Baltimore, Maryland.

TELO Stock Price History

TELO Stock News Headlines

Telomir Pharmaceuticals (NASDAQ:TELO) Trading Down 1.8%
See More Headlines
Receive TELO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Telomir Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/13/2024
Today
5/22/2024
Next Earnings (Estimated)
8/12/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:TELO
Previous Symbol
NASDAQ:TELO
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.10 per share

Miscellaneous

Free Float
N/A
Market Cap
$165.82 million
Optionable
N/A
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

TELO Stock Analysis - Frequently Asked Questions

How have TELO shares performed in 2024?

Telomir Pharmaceuticals' stock was trading at $5.00 at the beginning of the year. Since then, TELO stock has increased by 12.0% and is now trading at $5.60.
View the best growth stocks for 2024 here
.

When is Telomir Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024.
View our TELO earnings forecast
.

How were Telomir Pharmaceuticals' earnings last quarter?

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) posted its earnings results on Monday, May, 13th. The company reported ($0.23) earnings per share (EPS) for the quarter.

When did Telomir Pharmaceuticals IPO?

Telomir Pharmaceuticals (TELO) raised $7 million in an initial public offering on Friday, February 9th 2024. The company issued 1,000,000 shares at a price of $7.00 per share. Kingswood Investments acted as the underwriter for the IPO.

Who are Telomir Pharmaceuticals' major shareholders?

Telomir Pharmaceuticals' stock is owned by a number of retail and institutional investors. Top institutional investors include Suncoast Equity Management (0.08%).

How do I buy shares of Telomir Pharmaceuticals?

Shares of TELO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TELO) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners